¦V¤W Abnormal Bleeding Endometriosis PID Cervical Pregnancy Amenorrhea Chronic Pelvic Pain Ectopic Pregnancy interstitial pregnancy Periop management Pelvic mass Acute Pelvic Pain Endoscopic Myomectomy Nutritional Support ectopic pregnancy LAVH HRT candidiasis PMS Amenorrhea

~ Abnormal Bleeding ~

¤U¸ü MS Office .doc ÀÉ

¡@

Causes of Bleeding by Approximate Frequency and Age Group

Prepubertal

  • Vulvovaginal and external lesions
  • Foreign body
  • Precocious puberty
  • Tumor

Adolescent

  • Anovulation
  • Pregnancy
  • Exogenous hormone use
  • Coagulopathy

Reproductive

  • Pregnancy
  • Anovulation
  • Exogenous hormone use
  • Fibroids
  • Cervical and endometrial polyps
  • Thyroid dysfunction

Perimenopausal

  • Anovulation
  • Fibroids
  • Cervical and endometrial polyps
  • Thyroid dysfunction

Postmenopausal

  • Endometrial lesions, including cancer
  • Exogenous hormone use
  • Atrophic vaginitis
  • Other tumor: vulvar, vaginal, cervical.

¡@

Prepubertal Age Group

  1. Causes:

Vulvar and external

  • Vulvitis excoriation (due to vulvar irritation)
  • Trauma (eg. straddle injury)
  • Lichen sclerosus
  • Condyloma
  • Molluscum contagiosum
  • Urethral prolapse

Vaginal

  • Vaginitis
  • Vaginal foreign body
  • Trauma (abuse, penetration)
  • Vaginal tumor

Uterine

  • Precocious puberty

Ovarian tumor

¡@

Exogenous estrogens

  • Topical
  • Enteral

¡@

  1. Differential Diagnosis:
  1. Vulvar lesions:
  2. - Vulvar irritation: pruritis with excoriation, maceration of the vulvar skin, or fissures.

    - Urethral prolapse: a mass symmetrically surrounding the urethra

  3. Foreign body:
  4. - Vaginal discharge, shich may appear purulent or bloody

    - Rectal examination: An object can sometimes be palpated.

  5. Precocious puberty:
  6. Trauma:
  7. Others:
  1. Diagnosis:
  1. History and physical examination:
  2. Imaging studies: (on the conditions of R/O ovarian or vaginal tumors)
  3. - Ultrasound should be the first study performed

    - others: MRI, CT (rarely indicated)

    - The prepubertal uterus has a distinctive appearance, with equal proportions of cervix and fundus

    and a size of approximately 2-3.5 cm in length and 0.5-1 cm in width.

  4. Endoscopy:
  1. Management: directed to the causes of bleeding

- Skin lesions: a shout course of topical mild steroids.

- Urethral prolapse: topical estrogens

- Vaginal / ovarian tumors: à gynecologic oncologists.

¡@

Adolescence

  1. Normal Menses:

- During the first 2 years after menarche, most cycles are anovulatory

- Conditions considered out of the ordinary, particularly after the first 2 years after menarche:

  1. Cycles longer than 42 days
  2. Cycles shorter than 21 days
  3. Bleeding lasting more than 7 days
  1. Differential Diagnosis:
  2. 1. Anovulation:

    ¡± Conditions associated with anovulation:

    Eating disorders: anorexia nervosa, bulimia nervosa

    Excessive physical exercise

    Chronic illness

    Alcohol and other drug abuse

    Stress

    Thyroid diseases: hypothyroidism, hyperthyroidism

    DM

    Androgen excess syndrome

    ¡± Anovulatory bleeding can be too frequent, prolonged or heavy, particularly after a long interval

    of amenorrhea.

    2. Pregnancy-related bleeding: eg. spontaneous abortion, ectopic pregnancy, molar pregnancy, etc.

    3. Exogenous hormones: eg. oral contraceptives, missed pills, Norplant, etc

    4. Hematologic abnormalities:

    ¡± most common: idiopathic thrombocytopenic purpura

    ¡± followed by: Willebrand¡¦s disease

    5. Infections:

    ¡± Adolescents have the highest risks of PID and chlamydial infections of any age group.

    6. Other endocrine or systemic problems: eg. thyroid dysfunction, PCOS, etc.

    7. Anatomic causes:

  3. Diagnosis:
  4. - Sensitive pregnancy test:

    - Laboratory testing:

    ¡± CBC with coagulation studies and bleeding time, cultures for gonorrhea, tests for chlamydia

    infection, thyroid studies, etc.

    - Imaging studies: ultrasound, etc.

  5. Management:

- based on the appropriate diagnosis

(eg. pregnancy, thyroid dysfunction, hepatic abnormalities, hematologic abnormalities,

or androgen excess syndrome)

- In the absence of specific diagnosis, the assumption is that of anovulation or dysfunction bleeding.

- Mildly bleeding and mildly anemic:

¡± reassurance, close follow-up, supplemental iron

¡± hormonal therapy: (for 3-6 cycles)

? low-dose oral contraceptives: (eg. Nordette)

21-days hormonally active pills, followed by 7-days placebo, during which time

withdrawal bleeding is expected.

cyclic progestins are an alternate:

provera (5) 5-10 mg qd for 10-13 days

to prevent excessive endometrial building and irregular shedding caused

by unopposed estrogen stimulation

- Acute bleeding: moderate:

¡± hormone therapy with highter dose than oral contraceptive:

    1. combination monophasic oral contraceptives, q6h for 4-7 days,
    2. then tapered or stopped to allow withdrawal bleeding

    3. then low-dose oral contraceptive qd for 3-6 cycles to allow regular withdrawal flow

¥ Patient and her family should be warned about:

Side effects: nausea, breast tenderness, and breakthrough bleeding

Heavy withdrawal flow for the first period

- Acute bleeding: emergency management:

¡± hospitalization: based on the rate of bleeding and the severity of anemia

¡± for bleeding:

    1. measurement of coagulation and hemostasis
    2. blood transfusion: on the condition of hemodynamic instability

¡± If DUB is diagnosed after excluding other systemic or organic diseases,

ð hormonal therapy

    1. conjugated estrogens:
    2. ? premarin (25) 25-40 mg v. q6h

      premarin (1.25) 2.5 mg po q6h

      ¤ If hormonal therapy fails, a local cause of bleeding is likely.

    3. oral progestin for several days:
    4. withdrawal bleeding

    5. low-dose oral contraceptive for 3-6 cycles

¡± For patients with coagulopathies or malignancy requiring chemotherapy,

Ø long-term hormonal suppression of menstruation: (There are 4 choices.)

    1. continuous progestin: (eg. provera)
    2. continuous combination regimens of oral estrogen and progestins that do not include a withdrawal bleeding-placebo week
    3. depo-provera m., with or without concurrent estrogens
    4. GnRH analog

¡@

Reproductive Age Group

  1. Differential Diagnosis:
  1. Dysfunctional Uterine Bleeding:
  2. ? Definition: abnormal bleeding for which no specific cause has been found

    most often implying a mechanism of anovulation

    ƒ a diagnosis of exclusion

    « Relatively low levels of estrogen stimulation will result in irregular and prolonged bleeding,

    wherease higher sustained levels result in episodes of amenorrhea followed by acute heavy

    bleeding.

  3. Pregnancy-Related Bleeding:
  4. Exogenous Hormone:
  5. ? oral contraceptive:

    - during the first1-3 month, 20-40% of women have breakthrough bleeding

    à expectant management

    Norplant

    ƒ depo-provera

    « Non-hormonal cause should be considered, eg. chlamydial cervicitis.

  6. Endocrine Causes:
  7. eg. hyperthyroidism, hypothyroidism, DM, etc.

  8. Anatomic Causes:
  9. eg. myoma, endometrial polyp, cervical lesions, endocervical polyp, infectious cervical lesions,

    eversion of endocervical columnar epithelium, Nabothian cyst, etc.

  10. Coagulopathies and Other Hematologic Causes:
  11. Infectious Causes:
  12. eg. cervicitis particularly chlamydial cervicitis, endometritis, etc.

  13. Neoplasia:
  1. Diagnosis:
  1. History and Physical Examination (including PV)
  2. Laboratory Studies:
  3. À pregnancy test

    Á CBC: to detect anemia or thrombocytopenia

     PT, PTT, BT (helpful on diagnosis of Willebrand¡¦s disease)

  4. Imaging Studies:
  5. - Ultrasound is most useful.

  6. Others (based on individual situation):

- Cervical Biopsy: for cervical lesions

- Endometrial sampling (D&C): for endometrial polyps, hyperplasia or carcinoma.

  1. Management:
  1. Nonsurgical:
  2. À NSAID: Ponstan and Brufen have been shown to decrease menstrual flow by 30-50%.

    Á Hormonal therapy:

    a). low-dose oral contraceptive (eg. Nordette)

    b). progestins: for women who are not suited for estrogen

    - provera (5) 10 mg qd for 10 days per month

    - depo-provera

  3. Surgical:

- reserved for situations in which medical therapy fails or is contraindiated

- D&C

- others: hysteroscopy with resection of submucous myoma, laparoscopic myomectomy,

hysterectomy, etc.

¡@

¡@

Postmenopausal Women

  1. Etiology of Postmenopaual Bleeding:
  2. Factor

    Approximate Percentage

    Exogenous estrogens

    30%

    Atrophic endometritis/vaginitis

    30%

    Endometrial cancer

    15%

    Endometrial or cervical polyps

    10%

    Endometrial hyperplasia

    5%

    Miscellaneous

    (eg. cervical cancer, uterine

    sarcoma, urethral caruncle, trauma)

    ¡@

    10%

  3. Differential Diagnosis:
  1. Benign Causes:
  2. À HRT-related problems: eg. poor compliance

    Á atrophic vaginitis

    Â cervical polyps

    Ã endocervical polyps and others

  3. Neoplasia:

Ovarian, endometrial, or cervical malignancy

  1. Diagnosis:
  2. history, pelvic examination, pelvic ultrasound, biopsy, etc.

  3. Management: based on the individual cause

¬ atrophic vaginitis (diagnosed by exclusion?)

ã topical or systemic use of estrogen

­ cervical polyp: ã polypectomy

® others: see other files

¡@

Filename: Abnormal Bleeding

¡@